Japanese officials enter a Kobayashi Pharmaceutical factory to conduct an on-site inspection in Osaka City, on 30 March, 2024. Photo: AFP/ Mami Nagaoki
Previous
Children are evacuated from school 'during an exam' after threat made via email
Next
Insider Q&A: CIA's chief technologist's cautious embrace of generative AI